You just read:

Jupiter Orphan Therapeutics Announces Favorable Data Which Expands JOTROL's Applications to the Estimated $5 Billion Mitochondrial Rare Disease Market

News provided by

Jupiter Orphan Therapeutics, Inc.

Aug 22, 2018, 08:34 ET